This indicated that demographic information and certain laboratory tests (TBIL, ALB and PLT) could improve the diagnostic efficacy for liver cancers and highlighted the significance of the combined detection of serum AFP, AFP-L3% and PIVKA-II in the diagnosis of liver cancers. This evidence concerns the gene AFP and liver cancer.